KMDA
Kamada Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers):
breedte van houders -3.8% ·
aandelenstroom -6.0% ·
netto nieuwe posities -4.0%
· formule
Brede distributie: dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 27 | +5 | 2.57M | $19.13M | +6 | −1 |
| Q1 2026 | 22 | -3 | 2.50M | $509.41M | +1 | −4 |
| Q4 2025 | 25 | -1 | 2.61M | $442.17M | n/a | −1 |
| Q3 2025 | 12 | 0 | 1.99M | $13.83M | n/a | n/a |
| Q2 2025 | 9 | +2 | 1.71M | $13.25M | +2 | n/a |
| Q1 2025 | 6 | +2 | 1.56M | $10.32M | +2 | n/a |
| Q4 2024 | 4 | 0 | 1.20M | $7.32M | n/a | n/a |
| Q3 2024 | 4 | 0 | 1.28M | $6.90M | n/a | n/a |
| Q2 2024 | 4 | n/a | 993.01K | $4.93M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wells Fargo & Company/Mn | 603.62K | n/a | $427.99M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 839.30K | -3.8% | $5.93M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 3 | Marshall Wace ✦ | 196.95K | +25.9% | $1.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Goldman Sachs Group ✦ | 167.52K | +43.3% | $1.18M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 157.61K | -31.1% | $1.11M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 140.68K | +28.4% | $993,215 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 116.63K | +236.4% | $827,090 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 68.40K | +153.8% | $482,889 | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 9 | JPMorgan Chase ✦ | 57.28K | -30.1% | $404,383 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | UBS Group AG | 55.33K | n/a | $390,623 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | Bank Of America Corp /De/ | 39.66K | n/a | $280,028 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | BlackRock ✦ (passief) | 38.45K | +238.4% | $271,443 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Man Group plc | 34.29K | n/a | $242,116 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passief) | 29.41K | 0.0% | $207,627 | 0.0% | Held | 7 | SEC ↗ |
| 15 | Jane Street Group, Llc | 21.16K | n/a | $149,389 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 16 | Morgan Stanley ✦ | 12.41K | -81.8% | $87,622 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 17 | Envestnet Asset Management Inc | 10.13K | n/a | $71,532 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Focus Partners Wealth | 10.00K | n/a | $70,600 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Barclays Plc | 4.79K | n/a | $33,803 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Mirae Asset Global Investments Co.… | 2.80K | n/a | $19,789 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Citigroup Inc | 1.61K | n/a | $11,424 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Royal Bank Of Canada | 1.27K | n/a | $9,000 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bnp Paribas Financial Markets | 1.24K | n/a | $8,783 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Daiwa Securities Group Inc. | 192 | n/a | $1,000 | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Osaic Holdings, Inc. | 135 | n/a | $953 | 0.0% | n/c | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| ARK Investment Management | $1.78M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 41 houders, 5.10M aandelen, $528.34M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 22.83K aand · $186,725
Director · 175 aand · $1,446
Director · 162.76K aand · $1.34M
Director · 14.24K aand · $117,891
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie